Australian law-firm Minter Ellison has boosted its IP team after announcing that a patent and trademark litigator will be joining the firm and bringing a 13-strong team with them.
Wayne McMaster and Robert Cooper (pictured) will join the firm’s Melbourne office as partners.
The pair, who join from King & Wood Mallesons, will also carry across their combined portfolio of work.
John Weber, chief executive partner at Minter Ellison, said the firm is “well positioned” to take the opportunity to grow in areas of strong client demand and was “delighted” to welcome the pair.
“They are senior practitioners who have built a market-leading and widely respected litigation practice focussed on the pharmaceutical sector,” Weber said.
“Their arrival brings a new dimension to our commercial disputes and IP practices and will help to drive growth in those areas by opening up new client and market opportunities."
McMaster (below left) has been a patent attorney for more than 30 years and was head of the IP practice and health & pharma practice at King Wood & Mallesons. He also drafts and negotiates commercial technology agreements for the pharmaceutical and biotechnology industries."
Cooper (below right) is a registered trademark attorney and handles disputes, licensing issues and trademark registrations.He also has experience in patent disputes in areas including pharmaceutical compounds and processes, mobile telecommunications and consumer goods.
The lawyers joining McMaster and Cooper include a special counsel and three senior associates, as well as paralegals and support personnel.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at email@example.com
patent, trademark, pharmaceutical, partner, Minter Ellison